奧佳華(002614.SZ):控股股東方面合計持股比例因可轉債轉股被動稀釋至44.84%
格隆匯9月7日丨奧佳華(002614.SZ)公佈,公司於2020年2月25日公開發行的可轉換公司債券(“奧佳轉債”),自2020年9月2日起可轉換為公司股份。截至2020年9月2日,“奧佳轉債”轉股數量累計為3667.4901萬股,公司總股本由未實施轉股前的約5.6125億增加至約5.9793億股,導致公司控股股東鄒劍寒及其一致行動人李五令合計持股比例由未實施轉股前47.78%被動稀釋至44.84%,持股比例變動為2.94%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.